Back to LYEL

Verdad Advisers, LP → LYEL

Verdad Advisers, LP LYEL Position History

Lyell Immunopharma, Inc. • Healthcare

Quarters held
1
Latest value
$344K
Q3 2026
Peak value
$344K
First seen
Q3 2026

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$344K35.1K——

Other funds holding LYEL

Other Verdad Advisers, LP positions

C-PR

CITIGROUP INC

$4M
TJX

TJX COS INC NEW

$3.8M
JNJ

JOHNSON & JOHNSON

$3.6M
CCZ

COMCAST CORP NEW

$2.9M
CVX

CHEVRON CORP NEW

$2.8M
GOOGN

ALPHABET INC

$2.7M
LRCX

LAM RESEARCH CORP

$2.6M
STNG

TEGNA INC

$2.5M